AP Hemp Limited (APH) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return

System message

15 Nov 2019: Updates have been made to Broker Consensus and Highest Dividends.

Get these alerts in your email: Signup Free Here

AP Hemp Limited Chart

Share price
Last
Change
Volume
Turnover
Market Cap $9.8 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

APH Statistics

15 November

1,765 / 2,297

ASX Size Rank

1yr Return

vs Sector (1yr)

+1,674.59%

vs ASX 200 (1yr)

+1,699.74%

$9.8 million

Market Cap

Share Issue

49.01 million

All Ords (%)

N/A

Short Sold

0%

Current Fundamentals

15 November

N/A

PE Ratio

EPS ($)

-0.002

Earnings Yield

-0.80%

NTA ($)

-

N/A

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Australian Primary Hemp Limited (APH, formerly Alchemia Limited) engages in hemp growing and production services as well as handling in all areas of the hemp value chain, encompassing; hemp seed selection, farming, processing, packaging as well as distribution and sale of bulk and retail edible products.APH imports raw FINOLA hemp seeds from Canada and Finland.

Former Names
Alchemia Limited (ACL), 14/10/2019

AP Hemp Limited Logo

Corporate Details

Head Office: South Melbourne
Managing Director: -
GICS Sub-Industry: Pharmaceuticals
Date Listed: 23 Dec 2003
Registry: -
Similar Companies: MYX / SPL / CAN / MVP / NEU

Upcoming Calendar

26 Feb 2020 Report (Interim)
30 Jul 2020 Report (Prelim)
30 Jul 2020 Report (Annual)

Dividend History

Ex-Date Amount Franking Type Payable
01/02/2016 $0.093 0% Interim 24/02/2016

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

APH is not covered by a major broker.

Directors & Management

About the Data


Name Title Since Bio
Ms Melanie Jaye Leydin Chief Financial Officer, Company Secretary Apr 2016
Mr Cameron Petricevic Non-Executive Director, Non-Executive Chairman Jun 2018
Ms Pauline Therese Gately Non-Executive Director Oct 2019
Mr James Hood Non-Executive Director Oct 2019
Mr Charles Mann Non-Executive Director Oct 2019

Director Transactions

About the Data

APH directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
02/10/19 Cameron Petricevic Issued 4,196,500 $0.011 $46,161 Issue of securities.
02/10/19 Cameron Petricevic Issued 1,216,904 $0.011 $13,385 Issue of securities.

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 1,454 1,158 481 941 344 4,378

Top 20 Shareholders

About the Data

Name Shares Capital
Shomron Pty Ltd 39,426,777 12.14%
Ttor Pty Ltd 16,069,996 4.95%
HSBC Custody Nominees (Australia) Limited 12,658,835 3.90%
Mr Bilal Ahmad 8,100,000 2.49%
Mr Rick William Langdon 7,936,383 2.44%
Mr Andrew Richard Jackson Ball 7,112,630 2.19%
Mrs Ifrah Nishat 6,313,000 1.94%
California Capital Equity Llc 5,854,719 1.80%
Mr Paul Homewood 5,440,000 1.68%
Mr Jason Brett Randall 5,000,000 1.54%
Mr Brian Riess 5,000,000 1.54%
Mr Sufian Ahmad 4,100,000 1.26%
J P Morgan Nominees Australia Pty Limited 3,937,897 1.21%
Mr Arjunan Sundaramoorthy 3,400,000 1.05%
Maxlen Nominees Pty Ltd 3,394,730 1.05%
Tamborine Trees Pty Ltd 3,000,000 0.92%
Campbell Kitchener Hume & Associates Pty Ltd 2,800,000 0.86%
Dr Robert Julian Hafner 2,573,988 0.79%
Mr Garry Webb & Mrs Lorraine Webb 2,500,000 0.77%
Carojon Pty Ltd 2,500,000 0.77%
All other shareholders 54.71 %


The Top 20 Shareholders of APH hold 45.29% of shares on issue.

APH Share Price History

Date Close Change % Change Open High Low Volume Turnover

APH Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Closure of all Clinical trial activities and efforts to realise value from company owned intellectual property and Review of new opportunities with the aim of providing overall increase to shareholder value.

Incorporated: --

Level 4, 100 Albert Rd
South Melbourne VIC 3205


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.